CMV accelerates the signs of premature immunosenescence in JIA and RA patients.
CD69 and Ki67 expression in CD8+ T-cells is low in RA patients compare to age-matched controls.
CD28-CD8+ T-cells may control latent CMV infection regarless in vitro blockade of TNFα or IL-6 in CMV+ RA patients.